PATENT CLAIM ANALYSIS

Application Number: 15996723
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["546", "256000"]

Abstract:
Compounds and compositions comprising compounds that inhibit glutaminase are described herein. Also described herein are methods of using the compounds that inhibit glutaminase in the treatment of cancer.

Claim (Index 23):
The method of  claim 20 , wherein each W is \u2014CH\u2550, each Z is \u2014O\u2014 and each Y is \u2014N\u2550.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 94.0
- Lexical Diversity: 1.5
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14085947', '14646239', '14086003', '15127742', '14646634']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8071950224076331
- 35 USC 102 Novelty (BERT): 0.5647825698205184
- Combined Prediction Score: 0.7829537771489217
- Mean Citation Score: 416.439832
- Max Citation Score: 501.6011
- Similarity Product: 309.5082608369827

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test